Patient Readiness to Adhere to HAART
- 1 November 2009
- journal article
- Published by SAGE Publications in Journal of the International Association of Physicians in AIDS Care
- Vol. 8 (6) , 364-366
- https://doi.org/10.1177/1545109709351240
Abstract
Objectives: to determine 1) whether patients’ statements of readiness to take HAART predicted adherence and 2) whether previous experience with HAART enabled patients to better predict adherence. Method: Thirty-nine patients (24 naïve to HAART and 15 reinitiating HAART after a hiatus of >6 months) indicated readiness to take HAART on a Likert scale and a visual analog scale (VAS). Adherence was measured by prescription renewals. Results: Participants were 72% male; 62% African/American; 23% Anglo-White, and 13% Hispanic. Patients considered themselves quite ready to initiate therapy on both scales. Adherence for 5 months ranged from 24% to 100%; mean = 68%; median = 78%. Adherence was not associated with readiness as measured by the Likert scale (F = .15, p = .86) or the VAS (r = -.078, p = .64). VAS readiness scores did not correlate with adherence for naïve (r = -.16; p = .47) or experienced (r = .09; p = .76) patients. Conclusions: Patients’ statements of readiness to take HAART do not predict their adherence.Keywords
This publication has 9 references indexed in Scilit:
- Development and Validation of the HIV Medication Readiness ScaleAssessment, 2007
- Use of pharmacy refill data as a measure of antiretroviral adherenceCurrent HIV/AIDS Reports, 2007
- A randomized controlled psycho-education intervention trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAARTAIDS Care, 2006
- Development of Stage of Readiness and Decisional Balance Instruments: Tools to Enhance Clinical Decision-Making for Adherence to Antiretroviral TherapyAIDS and Behavior, 2006
- Starting or Changing Therapy – A Prospective Study Exploring Antiretroviral Decision–MakingInfection, 2005
- Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and deathInternational Journal of STD & AIDS, 2004
- Provider Assessment of Adherence to HIV Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Provider Assessment of Adherence to HIV Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000